Find trials
Search tips

Effect of Prolonged Fasting Time on Gastric Residual Volume in Patients Taking GLP1 Receptor Agonists

Overview

About this study

The purpose of this study is to determine whether a modified fasting protocol can reduce the potential risk of aspiration for patients currently prescribed GLP1-RAs.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Adults greater than or equal to 18 years of age, undergoing elective upper endoscopy with gastroenterology team

Exclusion Criteria: 

  • Urgent or emergent procedure, inclusion of colonoscopy or antegrade small bowel enteroscopy in planned procedure, upper GI barium study performed in past 24 hours, gastroparesis, achalasia, pancreatitis, use of outpatient pro-motility medications, patient refusal, inability for patient to provide own consent

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 3/14/2024. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Krishnan Ramanujan, M.D.

Open for enrollment

Contact information:

Krishnan Ramanujan M.D.

(507) 422-0662

Ramanujan.Krishnan@mayo.edu

More information

Publications

Publications are currently not available

More about research at Mayo Clinic

.
CLS-20586924

Mayo Clinic Footer